Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now

Core Viewpoint - Growth investors are increasingly focused on stocks with above-average financial growth, and Boston Scientific (BSX) is highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [2][10] Earnings Growth - Boston Scientific has a historical EPS growth rate of 17.6%, with projected EPS growth of 15.8% for the current year, surpassing the industry average of 12.5% [4] Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 26.5%, significantly higher than the industry average of -8.8% [5] - Over the past 3-5 years, Boston Scientific's annualized cash flow growth rate has been 9.9%, compared to the industry average of 7.9% [6] Earnings Estimate Revisions - There have been upward revisions in current-year earnings estimates for Boston Scientific, with the Zacks Consensus Estimate increasing by 2.2% over the past month [8]